会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 95. 发明授权
    • Synthetic immunogen useful for generating long lasting immunity and protection against pathogens
    • 用于产生持久免疫力和防止病原体的合成免疫原
    • US09340622B2
    • 2016-05-17
    • US13822881
    • 2011-09-14
    • Javed N. AgrewalaUthaman GowthamanDavid JacksonWeiguang Zeng
    • Javed N. AgrewalaUthaman GowthamanDavid JacksonWeiguang Zeng
    • A61K39/04A61K39/02A61K39/00C07K19/00
    • C07K19/00A61K39/04A61K2039/55516A61K2039/6018Y02A50/41Y02A50/412Y02A50/484
    • The present invention relates to a synthetic immunogen represented by the general formula 1, useful for generating long lasting protective immunity against various intracellular pathogens which are the causative agents of tuberculosis, leishmaniasis, AIDS, trypanosomiasis, malaria and also allergy, cancer and a process for the preparation thereof. The developed immunogen is able to circumvent HLA restriction in humans and livestock. The invention further relates to a vaccine comprising the said immunogen for generating enduring protective immunity against various diseases. The said vaccine is targeted against intracellular pathogens, more particularly the pathogen M. tuberculosis in this case. In the present invention, promiscuous peptides of M. tuberculosis are conjugated to TLR ligands especially; Pam2Cys to target them mainly to dendritic cells and therefore elicit long-lasting protective immunity. wherein, X1=a promiscuous CD4 T helper epitope selected from SEQ ID No. 1 to 98 OR nil; X2=a promiscuous CD8 T cytotoxic epitope selected from SEQ ID No. 99 to 103 OR nil; when X1=nil; X2=SEQ ID No. 99 to 103 and when X2=nil; X1=SEQ ID No. 1 to 98; Y=Lysine; and S=Serine.
    • 本发明涉及由通式1表示的合成免疫原,其可用于产生针对结核病,利什曼原虫病,艾滋病,艾滋病,锥虫病,疟疾和过敏,癌症的致病因子的各种细胞内病原体的长期保护性免疫,以及用于 其制备。 发达的免疫原能够规避人类和家畜的HLA限制。 本发明还涉及包含所述免疫原的疫苗,用于产生针对各种疾病的持久的保护性免疫。 在这种情况下,所述疫苗针对细胞内病原体,特别是病原体结核分枝杆菌。 在本发明中,结核分枝杆菌杂交肽特别与TLR配体结合; Pam2Cys将其主要靶向树突细胞,从而引发持久的保护性免疫。 其中X1 =选自SEQ ID No.1至98的杂交CD4T辅助表位或无; X2 =选自SEQ ID NO:99至103的混杂CD8 T细胞毒性表位或无; 当X1 = nil; X2 = SEQ ID No.99至103,当X2 = nil时; X1 = SEQ ID No.1至98; Y =赖氨酸; 和S =丝氨酸。
    • 98. 发明授权
    • Systems and methods for thermal control
    • 热控制系统和方法
    • US08766656B2
    • 2014-07-01
    • US13865005
    • 2013-04-17
    • Zafar MalikDavid Jackson
    • Zafar MalikDavid Jackson
    • G01R31/10G01R31/28
    • G01R31/2875G01R31/2877
    • The present invention relates generally to a system and a method for thermal control. More particularly, the invention encompasses an apparatus for thermal control and management of at least one device under test (DUT). The inventive thermal control and management apparatus also allows for the management of a plurality of devices under test, and with each device under test having its own testing regimen. The thermal control and management of the device under test (DUT) is managed using at least one thermoelectric element or cooler (TEC), which can be used to either heat or cool the corresponding device under test (DUT).
    • 本发明一般涉及用于热控制的系统和方法。 更具体地,本发明包括用于对至少一个待测器件(DUT)进行热控制和管理的装置。 本发明的热控制和管理装置还允许对被测试的多个设备进行管理,并且每个待测设备都具有其自己的测试方案。 被测设备(DUT)的热控制和管理使用至少一个热电元件或冷却器(TEC)进行管理,该热电元件或冷却器可用于加热或冷却相应的被测器件(DUT)。